Free Trial

PROCEPT BioRobotics (PRCT) Stock Price, News & Analysis

PROCEPT BioRobotics logo
$40.80 +0.28 (+0.69%)
Closing price 04:00 PM Eastern
Extended Trading
$40.88 +0.08 (+0.18%)
As of 05:49 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About PROCEPT BioRobotics Stock (NASDAQ:PRCT)

Key Stats

Today's Range
$40.03
$41.20
50-Day Range
$38.41
$60.22
52-Week Range
$37.12
$103.81
Volume
721,947 shs
Average Volume
1.02 million shs
Market Capitalization
$2.27 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$74.88
Consensus Rating
Moderate Buy

Company Overview

PROCEPT BioRobotics Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
74th Percentile Overall Score

PRCT MarketRank™: 

PROCEPT BioRobotics scored higher than 74% of companies evaluated by MarketBeat, and ranked 268th out of 945 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    PROCEPT BioRobotics has received a consensus rating of Moderate Buy. The company's average rating score is 2.78, and is based on 7 buy ratings, 2 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    PROCEPT BioRobotics has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about PROCEPT BioRobotics' stock forecast and price target.
  • Earnings Growth

    Earnings for PROCEPT BioRobotics are expected to grow in the coming year, from ($1.75) to ($1.27) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of PROCEPT BioRobotics is -26.32, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of PROCEPT BioRobotics is -26.32, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    PROCEPT BioRobotics has a P/B Ratio of 5.89. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about PROCEPT BioRobotics' valuation and earnings.
  • Percentage of Shares Shorted

    13.46% of the float of PROCEPT BioRobotics has been sold short.
  • Short Interest Ratio / Days to Cover

    PROCEPT BioRobotics has a short interest ratio ("days to cover") of 6.8.
  • Change versus previous month

    Short interest in PROCEPT BioRobotics has recently increased by 4.40%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    PROCEPT BioRobotics does not currently pay a dividend.

  • Dividend Growth

    PROCEPT BioRobotics does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    13.46% of the float of PROCEPT BioRobotics has been sold short.
  • Short Interest Ratio / Days to Cover

    PROCEPT BioRobotics has a short interest ratio ("days to cover") of 6.8.
  • Change versus previous month

    Short interest in PROCEPT BioRobotics has recently increased by 4.40%, indicating that investor sentiment is decreasing.
  • News Sentiment

    PROCEPT BioRobotics has a news sentiment score of 1.53. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.97 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 18 news articles for PROCEPT BioRobotics this week, compared to 8 articles on an average week.
  • Search Interest

    6 people have searched for PRCT on MarketBeat in the last 30 days. This is an increase of 20% compared to the previous 30 days.
  • MarketBeat Follows

    3 people have added PROCEPT BioRobotics to their MarketBeat watchlist in the last 30 days. This is an increase of 50% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, PROCEPT BioRobotics insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $6,271,250.00 in company stock.

  • Percentage Held by Insiders

    17.40% of the stock of PROCEPT BioRobotics is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    89.46% of the stock of PROCEPT BioRobotics is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about PROCEPT BioRobotics' insider trading history.
Receive PRCT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for PROCEPT BioRobotics and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

PRCT Stock News Headlines

BONUS GUIDE - Ben Stein Prepares For the Next Financial Crisis
With inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist Ben Stein—drawing on insights from his own experience and his father’s time advising two U.S. presidents—just released a new report on how to help protect your retirement from the next major crisis.tc pixel
See More Headlines

PRCT Stock Analysis - Frequently Asked Questions

PROCEPT BioRobotics' stock was trading at $80.52 at the beginning of 2025. Since then, PRCT shares have decreased by 49.3% and is now trading at $40.80.

PROCEPT BioRobotics Corporation (NASDAQ:PRCT) released its quarterly earnings data on Wednesday, August, 6th. The company reported ($0.35) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.41) by $0.06. The company's revenue for the quarter was up 48.3% on a year-over-year basis.
Read the conference call transcript
.

PROCEPT BioRobotics (PRCT) raised $126 million in an initial public offering (IPO) on Wednesday, September 15th 2021. The company issued 5,500,000 shares at $22.00-$24.00 per share.

PROCEPT BioRobotics' top institutional investors include Alliancebernstein L.P. (3.88%), Westfield Capital Management Co. LP (2.87%), Geode Capital Management LLC (2.35%) and State Street Corp (2.28%). Insiders that own company stock include Frederic H Moll, Reza Zadno, Morgan Colby Wood, Kevin Waters, Hisham Shiblaq, Alaleh Nouri and Antal Rohit Desai.
View institutional ownership trends
.

Shares of PRCT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that PROCEPT BioRobotics investors own include Invesco QQQ (QQQ), SPDR S&P 500 ETF Trust (SPY), Netflix (NFLX), Tesla (TSLA), NVIDIA (NVDA), SPDR Dow Jones Industrial Average ETF Trust (DIA) and Meta Platforms (META).

Company Calendar

Last Earnings
8/06/2025
Today
8/27/2025
Next Earnings (Estimated)
10/27/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED INSTRUMENTS
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:PRCT
CIK
1588978
Fax
N/A
Employees
430
Year Founded
N/A

Price Target and Rating

High Price Target
$99.00
Low Price Target
$55.00
Potential Upside/Downside
+84.8%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.78
Research Coverage
9 Analysts

Profitability

EPS (Trailing Twelve Months)
($1.55)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$91.41 million
Net Margins
-30.60%
Pretax Margin
-30.60%
Return on Equity
-23.73%
Return on Assets
-17.34%

Debt

Debt-to-Equity Ratio
0.13
Current Ratio
9.21
Quick Ratio
7.86

Sales & Book Value

Annual Sales
$274.95 million
Price / Sales
8.20
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$6.93 per share
Price / Book
5.85

Miscellaneous

Outstanding Shares
55,636,000
Free Float
45,955,000
Market Cap
$2.25 billion
Optionable
Optionable
Beta
1.05

Social Links

7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

This page (NASDAQ:PRCT) was last updated on 8/27/2025 by MarketBeat.com Staff
From Our Partners